Drawing for FEMILINA

USPTO serial 99900229

FEMILINA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PROPER, PAULINA GRETCHEN
Law office
TMO LAW OFFICE 138

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with FEMILINA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael R. Graif

Michael R. Graif Brown Rudnick LLP7 Times SquareNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Hormone replacement therapy preparationsACTIVE—
042Providing information about medical research in the field of hormone replacement therapy; Providing scientific research information in the field of hormone replacement therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2026DOCKASSIGNED TO EXAMINER—
Oct 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 23, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance